Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
出版年份 2021 全文链接
标题
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis
作者
关键词
-
出版物
JAMA Cardiology
Volume -, Issue -, Pages -
出版商
American Medical Association (AMA)
发表日期
2021-07-08
DOI
10.1001/jamacardio.2021.2241
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
- (2021) Javid Moslehi et al. JOURNAL OF CLINICAL INVESTIGATION
- Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor–Associated Myocarditis
- (2021) Paaladinesh Thavendiranathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immunomodulatory Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis: Pathway Toward Precision-Based Therapy
- (2020) Dinu Valentin Balanescu et al. CARDIOVASCULAR PATHOLOGY
- Cardio-Immuno-Oncology
- (2020) Vlad G. Zaha et al. CIRCULATION
- Recognition and Initial Management of Fulminant Myocarditis
- (2020) Robb D. Kociol et al. CIRCULATION
- Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
- (2020) Lili Zhang et al. EUROPEAN HEART JOURNAL
- Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis
- (2020) Magid Awadalla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tocilizumab for refractory severe immune checkpoint inhibitor–associated myocarditis
- (2020) J. Doms et al. ANNALS OF ONCOLOGY
- Heart-Specific Immune Responses in an Animal Model of AutoimmuneRelated Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation
- (2020) Mariella Bockstahler et al. CIRCULATION
- Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis
- (2020) Shira Peleg Hasson et al. Clinical Research in Cardiology
- Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
- (2020) Jianliang Yang et al. EUROPEAN JOURNAL OF CANCER
- Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities
- (2020) Yves Allenbach et al. AUTOIMMUNITY REVIEWS
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research
- (2020) Douglas B Johnson et al. LANCET ONCOLOGY
- A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention
- (2020) Spencer C Wei et al. Cancer Discovery
- Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience
- (2019) Katherine Lee Chuy et al. ONCOLOGIST
- Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors
- (2019) Maddalena Centanni et al. CLINICAL PHARMACOKINETICS
- Cardiovascular toxicities associated with immune checkpoint inhibitors
- (2019) Jiun-Ruey Hu et al. CARDIOVASCULAR RESEARCH
- Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
- (2019) Douglas B. Johnson et al. Journal for ImmunoTherapy of Cancer
- Myocarditis in the Setting of Cancer Therapeutics
- (2019) Marc P. Bonaca et al. CIRCULATION
- Diagnosis of immune checkpoint inhibitor-associated myocarditis: A systematic review
- (2019) Richeek Pradhan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fulminant Myocarditis
- (2019) Javid J. Moslehi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- (2019) Joe-Elie Salem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
- (2019) Yuqin Song et al. LEUKEMIA
- Immune checkpoint inhibitor associated myocarditis occurs in both high-grade and low-grade forms
- (2019) Samantha N. Champion et al. MODERN PATHOLOGY
- Immuno-oncology drug development goes global
- (2019) Jia Xin Yu et al. NATURE REVIEWS DRUG DISCOVERY
- Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
- (2018) Hongnan Mo et al. BRITISH JOURNAL OF CANCER
- Cardiac Complications Associated With Checkpoint Inhibition: A Systematic Review of the Literature in an Important Emerging Area
- (2018) Hassan Mir et al. CANADIAN JOURNAL OF CARDIOLOGY
- Severe ophthalmoplegia and myocarditis following the administration of pembrolizumab
- (2018) Fadi Nasr et al. EUROPEAN JOURNAL OF CANCER
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Unknown
- (2018) JOURNAL OF FORENSIC SCIENCES
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
- (2018) Tomas G. Neilan et al. ONCOLOGIST
- Immune Checkpoint Inhibitor–Associated Myositis
- (2018) Céline Anquetil et al. CIRCULATION
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
- (2018) Vanessa M. Ferreira et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor–Associated Hypertension and Vascular Disease
- (2017) Arvind K. Pandey et al. HYPERTENSION
- New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma
- (2017) Juliane Behling et al. MELANOMA RESEARCH
- Cardiovascular Toxicities Associated with Cancer Immunotherapies
- (2017) Daniel Y. Wang et al. Current Cardiology Reports
- Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment
- (2017) Sooraj John et al. Journal for ImmunoTherapy of Cancer
- Smoldering myocarditis following immune checkpoint blockade
- (2017) Timothy G. Norwood et al. Journal for ImmunoTherapy of Cancer
- Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab
- (2016) Tomonori Tadokoro et al. Circulation-Heart Failure
- Myocarditis as an immune-related adverse event with ipilimumab/nivolumab combination therapy for metastatic melanoma
- (2016) Anurag Mehta et al. MELANOMA RESEARCH
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
- (2016) Lucie Heinzerling et al. Journal for ImmunoTherapy of Cancer
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
- (2015) Heinz Läubli et al. Journal for ImmunoTherapy of Cancer
- 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
- (2014) Ezra A. Amsterdam et al. CIRCULATION
- A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods
- (2014) Mark Oremus et al. HEART FAILURE REVIEWS
- Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis
- (2013) Ron Blankstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
- (2013) Steven M. Bair et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Troponin elevation in coronary vs. non-coronary disease
- (2010) S. Agewall et al. EUROPEAN HEART JOURNAL
- Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
- (2009) Matthias G. Friedrich et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation